ReviewNanomaterials (Basel, Switzerland)2021
Emerging Hybrid Nanocomposite Photocatalysts for the Degradation of Antibiotics: Insights into Their Designs and Mechanisms.
Review in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 40 citations in OpenAlex.
- Harnessing Visible Light: MXene/g‑CPrecision chemistry · 2026Article
- Design and Application of Hetero-Multicomponent Metal Oxide Photocatalysts for Wastewater Treatment: Ti-Cu-Zn Catalysts and Future Research Directions.Molecules (Basel, Switzerland) · 2026Review
- Advances in NIR-II Fluorescent Nanoprobes: Design Principles, Optical Engineering, and Emerging Translational Directions.Micromachines · 2025Review
- Enhanced Photocatalytic Activity of CQDs-Modified Layered g-CNanomaterials (Basel, Switzerland) · 2025Article
- Design, synthesis, and optimization of a novel ternary photocatalyst for degradation of cephalexin antibiotic in aqueous solutions.Scientific reports · 2025Article
- Nanomaterial-Enhanced Hybrid Disinfection: A Solution to Combat Multidrug-Resistant Bacteria and Antibiotic Resistance Genes in Wastewater.Nanomaterials (Basel, Switzerland) · 2024Review
- Increased Range of Catalytic Activities of Immobilized Compared to Colloidal Gold Nanoparticles.Molecules (Basel, Switzerland) · 2023Article
- Impact of Antibiotics as Waste, Physical, Chemical, and Enzymatical Degradation: Use of Laccases.Molecules (Basel, Switzerland) · 2022Review
- Article
- Correlation Analysis of Pathological Features and Axillary Lymph Node Metastasis in Patients with Invasive Breast Cancer.Journal of immunology research · 2022Article
- Incorporation of Nonmetal Group Dopants into g-CNanomaterials (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The raising occurrence of antibiotics in the global water bodies has received the emerging concern due to their potential threats of generating the antibiotic-resistive and genotoxic effects into humans and aquatic species. In this direction, the solar energy assisted photocatalytic technique offers a promising solution to address such emerging concern and paves ways for the complete degradation of antibiotics with the generation of less or non-toxic by-products. Particularly, the designing of hybrid photocatalyticcomposite materials has been found to show higher antibiotics degradation efficiencies. As the hybrid photocatalysts are found as the systems with ideal characteristic properties such as superior structural, surface and interfacial properties, they offer enhanced photoabsorbance, charge-separation, -transfer, redox properties, photostability and easy recovery. In this context, this review study presents an overview on the recent developments in the designing of various hybrid photocatalytic systems and their efficiency towards the degradation of various emerging antibiotic pharmaceutical contaminants in water environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.